RV Failure: The Great Debates

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Subhasis Chatterjee, MD

Nicholas Teman, MD
Disclosure(s): Alexion Pharmaceuticals: Consultant (Ongoing)

Presentations

  1. ​​​​​​Debate 1: RV Failure After MV Surgery—First Line Right-Sided MCS
    Michael Tong, MD
    Disclosure(s): Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lifenet: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  2. Debate 1: RV Failure After MV Surgery—First Line VA ECMO
    Amy E. Hackmann, MD
    Disclosure(s): Medtronic: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness), Advisory Board (Ongoing)
     
  3. Rebuttal
     
  4. Discussion
     
  5. Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Inhaled Nitric Oxide
    Vikram Fielding-Singh, MD, JD
    Disclosure(s): Masimo: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); SeaStar Medkcal: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  6. Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Prostacyclin
    Kamrouz Ghadimi, MD MHSc
    Disclosure(s): Octapharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Up To Date: Consultant (Ongoing), Royalties (Ongoing)
     
  7. Rebuttal
     
  8. Discussion
     
  9. Debate 3: Severe RV Dysfunction Before LVAD - Pro Planned RVAD
    Christian Bermudez, MD
    Disclosure(s): Abbott: Advisory Board (Ongoing); Abiomed / Breethe: Advisory Board (Ongoing)
     
  10. Debate 3: Severe RV Dysfunction Before LVAD - Pro Watch and See
    Ashish Shah, MD
     
  11. Rebuttal
     
  12. Discussion
Activity summary
Available credit: 
  • 1.50 ABS Accredited CME
  • 1.50 ABTS Accredited CME
  • 1.50 AMA PRA Category 1 Credit™
Activity opens: 
03/01/2025
Activity expires: 
03/01/2028
Cost:
$0.00
Part of: 
2025 STS Annual Meeting Online: Critical Care and Perioperative Management Track
Rating: 
0

Available Credit

  • 1.50 ABS Accredited CME
  • 1.50 ABTS Accredited CME
  • 1.50 AMA PRA Category 1 Credit™

Price

Cost:
$0.00
Please login or register to take this course.

All of the relevant financial relationships listed for these individuals have been mitigated. Unless otherwise noted, speakers have nothing to disclose.

Moderators

Subhasis Chatterjee, MD

Nicholas Teman, MD
Disclosure(s): Alexion Pharmaceuticals: Consultant (Ongoing)

Presentations

  1. ​​​​​​Debate 1: RV Failure After MV Surgery—First Line Right-Sided MCS
    Michael Tong, MD
    Disclosure(s): Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Abiomed: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Lifenet: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
     
  2. Debate 1: RV Failure After MV Surgery—First Line VA ECMO
    Amy E. Hackmann, MD
     
  3. Rebuttal
     
  4. Discussion
     
  5. Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Inhaled Nitric Oxide
    Vikram Fielding-Singh, MD, JD
    Disclosure(s): Masimo: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); SeaStar Medkcal: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing)
     
  6. Debate 2: Inhaled Nitric Oxide vs Prostacyclin—Pro Prostacyclin
    Kamrouz Ghadimi, MD MHSc
    Disclosure(s): Octapharma: Research Grant (includes principal investigator, collaborator or consultant and pending grants as well as grants already received) (Ongoing); Up To Date: Consultant (Ongoing), Royalties (Ongoing)
     
  7. Rebuttal
     
  8. Discussion
     
  9. Debate 3: Severe RV Dysfunction Before LVAD - Pro Planned RVAD
    Christian Bermudez, MD
    Disclosure(s): Abbott: Advisory Board (Ongoing); Abiomed / Breethe: Advisory Board (Ongoing)
     
  10. Debate 3: Severe RV Dysfunction Before LVAD - Pro Watch and See
    Ashish Shah, MD
     
  11. Rebuttal
     
  12. Discussion